PhD Projects in Generative Biology

Accelerated Evolution

Apply Now

Project Summary

Darwinian evolution has shaped all life on earth. As scientists, we would like to harness these principles to create new molecules in real time - for example, to rapidly create therapeutic molecules to tackle pandemics.

However, the timescales of Darwinian evolution in living organisms are long and thus incompatible with fast discovery of new functions in the laboratory.

To overcome this limitation, we have established a synthetic orthogonal replication system in E. coli (EcORep) that enables selective and rapid mutation and selection exclusively on the DNA of interest without increasing the host genome's mutation rate. This technology allows us to create proteins with new functions in a few days.

The lab aims to leverage the orthogonal replication system for the accelerated evolution of complex biological functions to i) advance fundamental scientific understanding of molecular and cellular evolution, ii) develop biomolecules to tackle challenges in human-health, agriculture, and industry, and iii) generate large-scale enzyme datasets for training next generation protein design models.

Potential Supervisors  

  • Professor Jason Chin (Founding Director, GBI, EIT & Professor of Chemistry and Chemical Biology, Department of Chemistry, University of Oxford)
  • Dr Rongzhen Tian (Group Leader, GBI, EIT)

Skills Recommended

  • A Master’s Degree (or equivalent) in a relevant scientific discipline (e.g. Biology, Chemistry, Engineering, Computer Science)
  • Experience of hands-on research in a laboratory setting
  • Proven ability to work independently, think creatively, and solve complex problems
  • Experience with data analysis, automation platforms, or computational tools relevant to the field
  • Experience preparing publications and delivering scientific presentations
  • Strong organisational skills and the ability to manage multiple parallel workstreams
  • Excellent written and verbal communication skills, including the ability to collaborate across multidisciplinary teams
  • A proactive mindset and enthusiasm for working in a fast-paced, high-growth research environment

University DPhil Courses 

Relevant Literature

  • Tian, R. et al. Establishing a synthetic orthogonal replication system enables accelerated evolution in E. coli. Science 383, 421–426 (2024).
  • Rix, G. et al. Continuous evolution of user-defined genes at 1 million times the genomic mutation rate. Science 386, eadm9073 (2024).
  • Molina, R. S. et al. In vivo hypermutation and continuous evolution. Nat. Rev. Methods Prim. 2, 36 (2022).
Supervisors

We are bringing together experts from across the globe, with a shared drive to create lasting impact.

Director of the Oxford Vaccine Group, Ashall Professor of Infection & Immunity

Professor Sir Andrew Pollard

Correlates of Immunity

Director of the Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford.

Principal Scientist, Pathogen Program & Member of the Board of Directors

Professor Gil McVean

Principal Scientist, Pathogen Program & Member of the Board of Directors. Professor of Statistical Genetics at the Department of Statistics and the Nuffield Department of Medicine, University of Oxford.

Principal Scientist, Plant Biology Institute & Member of the Board of Directors

Professor Steve Kelly

Principal Scientist Plant Biology Institute & Member of the Board of Directors at EIT. Professor of Plant Sciences and Senior Research Fellow of the Queens College, University of Oxford.

Executive Director & Principal Scientist

Dr Danilo Jimenez Rezende

AI & Robotics Institute

Executive Director & Principal Scientist for AI & Robotics at EIT. Former Director at Google DeepMind.

Executive Director & Executive Vice President

Dr Matej Macak

AI & Robotics Institute

Executive VP, AI & Robotics at EIT. Chief Technologist at Every Cure.

Principal Scientist, Economics

Professor Andrew Scott CBE

Economics

Principal Scientist of Economics, Economics Professor at University of Oxford. Research covers economics and longevity in aging societies.

Executive Director & Principal Scientist, Materials & Devices for Life Sciences

Professor Hagan Bayley

Materials & Devices for Life Sciences

Professor of Chemical Biology at the University of Oxford. Founder of Oxford Nanopore Technologies. Fellow of the Royal Society.

Founding Director, Generative Biology Institute

Professor Jason Chin

Generative Biology Institute

Founding Director, of the Generative Biology Institute (GBI) and Professor of Chemistry and Chemical Biology at the University of Oxford.

Research Scientist

Dr Ben Chamberlain

AI & Robotics Institute

Research Scientist in the AI & Robotics Institute at EIT. Previously held leadership roles at biotechs Isomorphic Labs and Charm Therapeutics.

Senior Director Device Science

Dr James Clarke

Senior Director of Product Science in the Pathogen Project at EIT.

Principal Investigator

Dr Jérôme Zürcher

Generative Biology Institute

Principal Investigator within GBI at EIT. Former junior research fellow at Trinity College, Cambridge and visiting researcher at the Innovative Genomics Institute at UC Berkeley.

Group Leader

Dr Linna Zhou

Materials & Devices for Life Sciences
Program Co-Lead

Professor Daniela Ferreira

Correlates of Immunity

Professor of Mucosal Immunology and Vaccinology at the Oxford Vaccine Group, Paediatrics Department, University of Oxford.

Senior Director, Science Applications

Professor Justin O'Grady

Pathogen Program

Senior Director of Science Applications in the Pathogen Program at EIT. Honorary Professor at the University of East Anglia.

Senior Group Leader

Professor Yujia Qing

Materials & Devices for Life Sciences

A Senior Group Leader in the Materials & Devices for the Life Sciences program at EIT. An Associate Professor in the Department of Chemistry, University of Oxford

Staff Scientist, AMR and Applied Metagenomics

Dr Vicky Enne

Pathogen Program
Senior Group Leader, Cell Based Production

Professor Lee Sweetlove

Plant Biology Institute